Abbott Laboratories (ABT) vs Medtronic PLC (MDT)
Abbott Laboratories and Medtronic PLC are both Medical Devices companies. Abbott Laboratories is the larger, with a market value of $174.8B against $112.2B — 1.6× the size. Medtronic PLC trades at the lower P/E: 21.7× against 32.8×. Medtronic PLC grew revenue faster over the last twelve months: 9.77% against 8.06%. Medtronic PLC has the higher net margin (13.9% vs 11.7%) and the higher return on invested capital (6.04% vs 5.83%). Both pay a dividend; Medtronic PLC yields more (3.07% vs 1.88%). Across the 23 metrics below, Medtronic PLC leads on 18 and Abbott Laboratories on 5.
Valuation
Profitability
| Metric | ABT | MDT | Medical Devices median |
|---|---|---|---|
| Gross margin | 56.61% | 65.01% | 56.01% |
| Operating margin | 15.77% | 18.08% | (15.03%) |
| Net margin | 11.65% | 13.93% | (20.40%) |
| Free cash flow margin | 16.80% | 16.33% | (7.24%) |
| Return on equity | 10.58% | 10.57% | (15.32%) |
| Return on assets | 5.62% | 5.68% | (19.72%) |
| Return on invested capital | 5.83% | 6.04% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack